Restoration of p53 function leads to tumour regression in vivo A Ventura, DG Kirsch, ME McLaughlin, DA Tuveson, J Grimm, L Lintault, ... Nature 445 (7128), 661-665, 2007 | 2206 | 2007 |
An X-ray computed tomography imaging agent based on long-circulating bismuth sulphide nanoparticles O Rabin, J Manuel Perez, J Grimm, G Wojtkiewicz, R Weissleder Nature materials 5 (2), 118-122, 2006 | 1075 | 2006 |
Noninvasive cell-tracking methods MF Kircher, SS Gambhir, J Grimm Nature reviews Clinical oncology 8 (11), 677-688, 2011 | 585 | 2011 |
Drug/dye‐loaded, multifunctional iron oxide nanoparticles for combined targeted cancer therapy and dual optical/magnetic resonance imaging S Santra, C Kaittanis, J Grimm, JM Perez small 5 (16), 1862-1868, 2009 | 437 | 2009 |
A spatially and temporally restricted mouse model of soft tissue sarcoma DG Kirsch, DM Dinulescu, JB Miller, J Grimm, PM Santiago, NP Young, ... Nature medicine 13 (8), 992-997, 2007 | 369 | 2007 |
Cerenkov luminescence imaging of medical isotopes A Ruggiero, JP Holland, JS Lewis, J Grimm Journal of Nuclear Medicine 51 (7), 1123-1130, 2010 | 340 | 2010 |
Randomized study to compare PTA alone versus PTA with Palmaz stent placement for femoropopliteal lesions J Grimm, S Müller-Hülsbeck, T Jahnke, C Hilbert, J Brossmann, M Heller Journal of Vascular and Interventional Radiology 12 (8), 935-941, 2001 | 265 | 2001 |
FDA-approved ferumoxytol displays anti-leukaemia efficacy against cells with low ferroportin levels V Trujillo-Alonso, EC Pratt, H Zong, A Lara-Martinez, C Kaittanis, ... Nature nanotechnology 14 (6), 616-622, 2019 | 256 | 2019 |
Nanoparticles for imaging: top or flop? F Kiessling, ME Mertens, J Grimm, T Lammers Radiology 273 (1), 10-28, 2014 | 248 | 2014 |
Tomographic fluorescence mapping of tumor targets X Montet, V Ntziachristos, J Grimm, R Weissleder Cancer Research 65 (14), 6330-6336, 2005 | 215 | 2005 |
Novel nanosensors for rapid analysis of telomerase activity J Grimm, JM Perez, L Josephson, R Weissleder Cancer Research 64 (2), 639-643, 2004 | 210 | 2004 |
Utilizing the power of Cerenkov light with nanotechnology TM Shaffer, EC Pratt, J Grimm Nature nanotechnology 12 (2), 106-117, 2017 | 201 | 2017 |
Non-invasive mapping of deep-tissue lymph nodes in live animals using a multimodal PET/MRI nanoparticle DLJ Thorek, D Ulmert, NFM Diop, ME Lupu, MG Doran, R Huang, ... Nature communications 5 (1), 3097, 2014 | 183 | 2014 |
Clinical Cerenkov luminescence imaging of 18F-FDG DLJ Thorek, CC Riedl, J Grimm Journal of Nuclear Medicine 55 (1), 95-98, 2014 | 179 | 2014 |
Quantitative imaging of disease signatures through radioactive decay signal conversion DLJ Thorek, A Ogirala, BJ Beattie, J Grimm Nature medicine 19 (10), 1345-1350, 2013 | 178 | 2013 |
The ancillary effects of nanoparticles and their implications for nanomedicine EP Stater, AY Sonay, C Hart, J Grimm Nature Nanotechnology 16 (11), 1180-1194, 2021 | 175 | 2021 |
Prostate-specific membrane antigen cleavage of vitamin B9 stimulates oncogenic signaling through metabotropic glutamate receptors C Kaittanis, C Andreou, H Hieronymus, N Mao, CA Foss, M Eiber, ... Journal of experimental medicine 215 (1), 159-175, 2018 | 171 | 2018 |
Cerenkov imaging-a new modality for molecular imaging DLJ Thorek, R Robertson, WA Bacchus, J Hahn, J Rothberg, BJ Beattie, ... American journal of nuclear medicine and molecular imaging 2 (2), 163, 2012 | 166 | 2012 |
Use of gene expression profiling to direct in vivo molecular imaging of lung cancer J Grimm, DG Kirsch, SD Windsor, CFB Kim, PM Santiago, V Ntziachristos, ... Proceedings of the National Academy of Sciences 102 (40), 14404-14409, 2005 | 165 | 2005 |
Tracking the recruitment of diabetogenic CD8+ T-cells to the pancreas in real time A Moore, J Grimm, B Han, P Santamaria Diabetes 53 (6), 1459-1466, 2004 | 161 | 2004 |